Ala. AG Loses Bid To Revive $275M AWP Cases

Law360, New York (January 22, 2010, 6:37 PM EST) -- The Alabama Supreme Court has refused to reconsider its reversal of two jury decisions that had awarded the state nearly $275 million from Novartis Pharmaceuticals Corp., GlaxoSmithKline and AstraZeneca LP, putting to rest the bellwether prescription drug price-fixing case.

In an 8-1 judgment without opinion, the high court on Friday denied Alabama Attorney General Troy King's application for rehearing and reconsideration — a ruling that could pave the way for the dismissal of 70 similar actions in state courts.

Although at trial, King had prevailed on...
To view the full article, register now.